Related Experiment Video
Updated: Aug 21, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Wnt signaling: physiology and pathology
Céline Prunier1, Barbara A Hocevar, Philip H Howe
1Department of Cell Biology, NC1, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Abstract:
Signaling by the Wnt family of secreted glycoproteins has been demonstrated to be essential both in normal embryonic development and in the pathogenesis of a variety of diseases, including cancer. This signaling pathway is exquisitely regulated by a large and complex array of proteins, which act as agonists or antagonists of signal transduction, modulating the Wnt signal extracellularly, in the cytoplasm and in the nucleus. Here, we will briefly review the canonical Wnt signaling pathway and consider molecular defects in Wnt signaling components known to promote uncontrolled cell growth following induction of Wnt signaling. We will also focus on two recently identified factors in this pathway, that seem to act as Wnt signaling antagonists, one functioning in the cytoplasm called Disabled-2 and the other in the nucleus named Chibby.
Insights
Wnt signaling, crucial for development and disease, is tightly regulated by proteins. This review covers Wnt pathway defects and highlights two antagonists: Disabled-2 and Chibby.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cell Signaling
Background:
- Wnt signaling is vital for embryonic development.
- Aberrant Wnt signaling contributes to diseases like cancer.
- The pathway involves complex regulation by agonists and antagonists.
Purpose of the Study:
- To review the canonical Wnt signaling pathway.
- To discuss molecular defects causing uncontrolled cell growth.
- To highlight two novel Wnt signaling antagonists: Disabled-2 and Chibby.
Main Methods:
- Literature review of Wnt signaling.
- Analysis of molecular defects in Wnt pathway components.
- Focus on cytoplasmic (Disabled-2) and nuclear (Chibby) antagonists.
Main Results:
- Wnt pathway dysregulation can lead to uncontrolled cell proliferation.
- Disabled-2 acts as a cytoplasmic antagonist.
- Chibby functions as a nuclear antagonist.
Conclusions:
- Understanding Wnt pathway regulation is key to addressing related diseases.
- Disabled-2 and Chibby represent important negative regulators of Wnt signaling.
- Further research into these antagonists may offer therapeutic targets.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
